Task: Answer the multiple choice question.
Query: Which compound exhibits a -1.133% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CN1N=C(C(=O)NC2CCCc3c2cnn3-c2ccc(F)cc2F)CCC1=O
(b) CCOC(=O)c1c2c([nH]c(=S)c1C#N)CCCC2
Answer: a. CN1N=C(C(=O)NC2CCCc3c2cnn3-c2ccc(F)cc2F)CCC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1N=C(C(=O)NC2CCCc3c2cnn3-c2ccc(F)cc2F)CCC1=O
CN1N=C(C(=O)NC2CCCc3c2cnn3-c2ccc(F)cc2F)CCC1=O
N-[1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-1-methyl-6-oxo-4,5-dihydropyridazine-3-carboxamide